With the holiday season around the corner, consumers are busy searching for the products to buy while investors are busy searching for the companies whose products consumers are buying. Just a couple of week back GoPro (NSDQ:GPRO) was one such company on which investors were willing to bet as its products were likely to fly off the shelves of retail outlets. But then the things changed. While GoPro's flagship Hero 5 camera continues to enjoy strong demand, same can't be said for its stock. The stock has tanked 30% in last one month due to multiple reasons, and many investors don't see any future prospect for the company. But there are also investors who feel that GoPro stock has over corrected. So the question is whether GoPro stock is a value trap or a value buy?
Lower Multiples, But Cheaper Valuations?The recent crash in GoPro's stock price has brought the valuation multiples to the ground. GoPro's PS ratio has declined from 2.2 in early October to 1.3 as of Friday. GoPro is currently trading at a market cap of $1.41 billion (50% down in last one year) and analysts expect GoPro's 2017 revenue to come in at $1.46 billion, giving it a forward PS of less than one. Many investors consider such low multiples as an attractive buying opportunity. But what investors must keep in mind is that lower multiples don't automatically mean cheaper valuations. A stock can have lower valuations than its peers and even its historical average and still remain expensive. There are analysts who are pointing to the fact that two years back GoPro was having similar revenue as of today but was trading at $50 a share and concluding that the stock is undervalued now. But I think the stock was overvalued then. Also, the narrative in the past two years has changed, for the worse.
Top Undervalued Stocks To Invest In Right Now: Cott Corporation(COT)
Advisors' Opinion:- [By Stephan Byrd]
Cott (NYSE:COT) (TSE:BCB) last announced its quarterly earnings results on Thursday, May 3rd. The company reported ($0.02) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.02). Cott had a net margin of 14.54% and a return on equity of 1.79%. The firm had revenue of $560.80 million for the quarter, compared to analyst estimates of $563.81 million. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. sell-side analysts anticipate that Cott will post 0.21 earnings per share for the current fiscal year.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Cott (COT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Cott (NYSE:COT) (TSE:BCB) was upgraded by analysts at Jefferies Group from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, MarketBeat reports. The firm currently has a $17.00 price objective on the stock. Jefferies Group’s price target indicates a potential upside of 6.25% from the stock’s previous close. Jefferies Group also issued estimates for Cott’s Q2 2018 earnings at $0.06 EPS, Q3 2018 earnings at $0.14 EPS, Q4 2018 earnings at $0.01 EPS and FY2020 earnings at $0.38 EPS.
- [By Joseph Griffin]
Cott Corp (NYSE:COT) (TSE:BCB) Director Steven P. Stanbrook purchased 13,500 shares of the company’s stock in a transaction dated Tuesday, February 26th. The stock was purchased at an average price of $14.77 per share, with a total value of $199,395.00. Following the transaction, the director now owns 13,500 shares of the company’s stock, valued at $199,395. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
- [By Max Byerly]
Cott Corp (NYSE:COT) (TSE:BCB) saw strong trading volume on Thursday . 1,847,700 shares changed hands during mid-day trading, an increase of 115% from the previous session’s volume of 860,693 shares.The stock last traded at $15.64 and had previously closed at $15.51.
Top Undervalued Stocks To Invest In Right Now: Zimmer Biomet Holdings, Inc.(ZBH)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on Zimmer Biomet (ZBH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
ILLEGAL ACTIVITY NOTICE: “Zimmer Biomet Holdings Inc (ZBH) Shares Bought by Cerity Partners LLC” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4153424/zimmer-biomet-holdings-inc-zbh-shares-bought-by-cerity-partners-llc.html.
- [By Joseph Griffin]
Natixis increased its position in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 25.8% during the second quarter, HoldingsChannel reports. The firm owned 151,024 shares of the medical equipment provider’s stock after buying an additional 30,988 shares during the quarter. Natixis’ holdings in Zimmer Biomet were worth $16,830,000 as of its most recent SEC filing.
- [By ]
Known for its hip and knee transplants, Zimmer Biomet (NYSE: ZBH) is much more than just orthopedics. But its core business has fully matured, and its expected revenue growth is extremely slow (only 0.6% in fiscal 2019, down from 1.4% this year and 2.6% in 2017). And profits are likely to stagnate, too, due partly to gross margin pressure. Until there are signs of acceleration, stay away from this stock.
- [By Ethan Ryder]
Highlander Capital Management LLC decreased its stake in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 66.7% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,428 shares of the medical equipment provider’s stock after selling 14,850 shares during the quarter. Highlander Capital Management LLC’s holdings in Zimmer Biomet were worth $828,000 at the end of the most recent reporting period.
- [By Joseph Griffin]
Zimmer Biomet Holdings Inc (NYSE:ZBH) VP Chad F. Phipps sold 30,100 shares of the stock in a transaction dated Friday, September 21st. The shares were sold at an average price of $132.37, for a total value of $3,984,337.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Top Undervalued Stocks To Invest In Right Now: Nuveen Massachusetts Premium Income Municipal Fund(NMT)
Advisors' Opinion:- [By Joseph Griffin]
News articles about Nuveen Massachusetts Pre Income Mun Fd (NYSE:NMT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nuveen Massachusetts Pre Income Mun Fd earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 47.5987310031013 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Top Undervalued Stocks To Invest In Right Now: Woori Bank(WF)
Advisors' Opinion:- [By Joseph Griffin]
News headlines about Woori Bank (NYSE:WF) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Woori Bank earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.2147954877183 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
- [By Stephan Byrd]
Woori Bank (NYSE:WF) and ANZ (OTCMKTS:ANZBY) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Wells Fargo (WF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Undervalued Stocks To Invest In Right Now: Mechel OAO(MTL)
Advisors' Opinion:- [By Logan Wallace]
Media coverage about Mechel PAO (NYSE:MTL) has been trending somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Mechel PAO earned a news impact score of 0.17 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.3523753315597 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
- [By Max Byerly]
Mullen Group Ltd (TSE:MTL) reached a new 52-week high on Friday . The company traded as high as C$15.38 and last traded at C$15.38, with a volume of 248494 shares. The stock had previously closed at C$14.72.
- [By Joseph Griffin]
Mullen Group Ltd (TSE:MTL) declared a monthly dividend on Wednesday, June 20th, Zacks reports. Shareholders of record on Saturday, June 30th will be paid a dividend of 0.05 per share on Monday, July 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend is Thursday, June 28th.
- [By Money Morning News Team]
Mechel Mining Co. (NYSE: MTL) is one of Russia's largest mining and metal companies, focusing on the production of coal, iron ore, steel and silver.
No comments:
Post a Comment